Navigation Links
Study identifies factors linked with better medication response for treatment of juvenile arthritis
Date:11/6/2011

e response, and 57 with a poor response.

"In a secondary analysis of 262 patients with a median follow-up of 35.6 months after initiation of etanercept, a range of 37 percent to 49 percent of patients reached inactive disease. [Average] drug survival [i.e., average duration from start until first discontinuation due to ineffectiveness or adverse events] was 49.2 months for patients with an excellent response after 15 months, 47.5 months for patients with an intermediate response, and 17.4 months for patients with a poor response," the authors write.

During etanercept treatment, patients experienced a total of 31 serious, 99 infectious, and 179 noninfectious adverse events.


'/>"/>
Contact: Marieke H. Otten, M.D., M.Sc.
m.otten@erasmusmc.nl
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Food Challenges Provide Best Allergy Diagnoses: Study
2. Pregnancy Safe for Most Women With Lupus: Study
3. Mayo Clinic study finds CT scans can help detect gout cases traditional tests miss
4. Common Breast Cancer Gene Test May Be Flawed, Study Says
5. Buyer, Beware of Over-the-Counter Thyroid Supplements: Study
6. New study from NYUCN is the first to look at nursing error disclosure in nursing homes
7. Brain Stimulation May Help Kill Cigarette Cravings, Study Finds
8. Too Much Sitting Raises Odds for Cancer: Study
9. Study Finds No Link Between Dyslexia and IQ
10. Study identifies an expanded role for PKM2 in helping cancer cells survive
11. Latex gloves lead to lax hand hygiene in hospitals, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Dr. Mark Sowell recently returned from leading a ... programs for advanced education in the field of dentistry, Spear ... As a visiting faculty member of this prestigious institution, Dr. ... he visits Spear Education to participate in a specialized workshop. ... training only the top 10% and those willing to sacrifice ...
(Date:3/6/2015)... 06, 2015 Medical Products, Inc., a ... agreement with GE Healthcare to become an authorized distributor ... States. , MPI has 31 years in distribution within ... , With this agreement, MPI will have the opportunity ... healthcare industry. , MPI has always strived to ...
(Date:3/6/2015)... 06, 2015 The Public Health ... five-year accreditation status to seven more health departments. This ... 1.3 million people can now be assured that their ... the health of their communities. , Public health departments ... health of people and communities. Across the nation, health ...
(Date:3/5/2015)... In 2014, the FDA approved 44 ... the list scoring 4 drug approvals in the USA. ... FDA approved drug products, followed by oncology therapy with ... anti-PD1 and CDK inhibitors keep on attracting large-cap pharmacos. ... to treat metastatic melanoma, and at present, they are ...
(Date:3/5/2015)... New York, NY (PRWEB) March 05, 2015 ... first time in more than a decade. She has hinted ... not want to miss seeing her perform one last time. ... two years and this beloved country sweetheart has millions of loyal ... be touring throughout her native country, Canada, and on June 30th ...
Breaking Medicine News(10 mins):Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3
... way to foil a tumor from generating blood vessels to ... by creating drugs aimed at stopping a key vessel growth-promoting ... , Researchers at the Moores Cancer Center at the University ... evidence that blocking that protein target, called VEGF, or vascular ...
... LegalView informed its readers of serious drug reactions and fatalities, which ... known as Heparin. The drug, from Baxter Healthcare, was found to ... ... Denver (PRWEB) November 9, 2008 -- LegalView.com, the number one ...
... #283-285, Ernest N. Morial Convention Center) , A team of ... key proteins out of thousands secreted into blood draining from ... quantities form the basis of a far more accurate early ... in people with severely reduced blood flow, or ischemia. ...
... they could cause interference when placed too closely to ... Tucking the headphones for your iPod into your coat ... interfere with the normal functioning of your implanted cardiac ... the American Heart Association,s annual scientific sessions, in New ...
... 57 percent less likely than Caucasian patients to ... year after successful angioplasty, a type of percutaneous ... coronary arteries. Hispanics also had a trend ... including stenting and bypass surgery, according to a ...
... release is available in French . ... international researchers including scientists from the McGill University ... that having high levels of particular protein puts patients ... of the study were so conclusive that the clinical ...
Cached Medicine News:Health News:Cancer drugs my build and not tear down blood vessels 2Health News:Cancer drugs my build and not tear down blood vessels 3Health News:LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin 2Health News:LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin 3Health News:LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin 4Health News:Quintet of proteins forms new, early-warning blood test before heart attack strikes 2Health News:Quintet of proteins forms new, early-warning blood test before heart attack strikes 3Health News:Quintet of proteins forms new, early-warning blood test before heart attack strikes 4Health News:MP3 Player Headphones May Throw Off Cardiac Devices 2Health News:MP3 Player Headphones May Throw Off Cardiac Devices 3Health News:Hispanics less likely to have repeat revascularizations 1 year after angioplasty 2Health News:Researchers discover new risk factor for cardiovascular disease, and a way to control it 2
(Date:3/5/2015)...  ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... the approved abbreviated new drug application ("ANDA") for ... previously marketed by Teva Pharmaceuticals.  According to IMS ... approximately $39 million in 2014.   ... of ANI Pharmaceuticals, stated, "This acquisition further expands ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/gl7m98/japan_pharma ) has ... 2015: Year to Watch out for Authorized Generics (AGs), ... offering. The new pricing system adopted ... (Annexure 1) is a game changer initiative. It pains ... The most of the companies are revalidating their domestic ...
(Date:3/5/2015)... 2015 Hitachi Medical Systems ... OASIS *    at ECR 2015 - the ... set a benchmark for patient-centric care. The new features ... whilst optimizing workflow management and costs. OASIS demonstrates the ... for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, Vascular and ...
Breaking Medicine Technology:ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3
... , VIENNA, Va. , Feb. 16 /PRNewswire-FirstCall/ -- ... results for the quarter ended December 31, 2009 . , CEL-SCI ... December 31, 2009 was $19,159,517 versus a loss of ... income per share, basic was $0.10 for the quarter ended ...
... , , MIAMI , ... now have access to high-level, FDA support services at ... International) has pioneered a "Virtual GMP Consulting" service.  Through ... collaboration software, Pharmaceutical manufacturers now have access to GMP ...
Cached Medicine Technology:CEL-SCI Corporation Reports First Quarter 2010 Financial Results 2CEL-SCI Corporation Reports First Quarter 2010 Financial Results 3CEL-SCI Corporation Reports First Quarter 2010 Financial Results 4CEL-SCI Corporation Reports First Quarter 2010 Financial Results 5VPCI Pioneers 'Virtual GMP Consulting' for FDA Pharmaceutical Manufacturers 2
... flexible continuous monitoring, the M3 and M4 ... and neonatal patient care. M Series monitors ... includes a basic set of non-invasive parameters ... Optional Multi-Measurement Server extensions offer Mainstream or ...
... the patients side and in transit., ... measurements in a compact package to match ... care, lower acuity environments, and patient transfer., ... patient monitoring, the IntelliVue MP20 Junior has ...
Compact networked patient monitors for flexible care....
... High-performance monitoring for flexible care settings., ... monitors combine portability and measurement flexibility ... needs of intermediate care environmentsat the ... strong heritage in patient monitoring, IntelliVue ...
Medicine Products: